• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

What to call someone who uses heroin?

Bioengineer by Bioengineer
July 16, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

First-ever study to ask people who use heroin what they want to be called finds ‘people first’ language often best, and language suggesting misuse or dependence generally worst

First-ever study to ask people who use heroin what they want to be called finds “people first” language often best, and language suggesting misuse or dependence generally worst.

In the ongoing opioid crisis, many researchers and clinicians now use “person first” terms such as “person with substance use disorder” instead of loaded labels like “addict,” but little research has focused on the language preferences of this population. Now, a first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) and the University of Massachusetts Medical School (UMMS), published in the journal Addiction, has found that people entering treatment for heroin use most often called themselves “addicts,” but preferred that others called them “people who use drugs.”

“In the end, researchers, clinicians, and families should not automatically use the same terms that people who use heroin call themselves, but instead ask about preferences,” says senior study author Dr. Michael Stein, professor and chair of health law, policy & management at BUSPH. “Of course, most people just want to be called by their name.”

The researchers surveyed 263 people undergoing in-patient evaluation and withdrawal symptom management at the Stanley Street Treatment and Resources program (SSTAR) in Fall River, Massachusetts. The terms that the most respondents never wanted to be called were “heroin misuser” and “heroin-dependent,” and most did not like slang terms such as “junkie.”

“Persons who use heroin often complain about interactions with healthcare providers, due at least in part to the unfortunate language providers use–which is taken, sometimes rightly, as a sign of disrespect,” Stein says. “Such antagonism can’t be good for clinical outcomes.”

“We hope this research will inform future work centering on the perspectives of individuals who use drugs, and begin to establish connections between the language that individuals use to describe themselves and treatment engagement,” says the study’s lead author, Dr. Ekaterina Pivovarova, assistant professor of psychiatry at UMMS and faculty in the Massachusetts Center of Excellence for Specialty Courts.

###

About the Boston University School of Public Health

Founded in 1976, the Boston University School of Public Health is one of the top five ranked private schools of public health in the world. It offers master’s- and doctoral-level education in public health. The faculty in six departments conduct policy-changing public health research around the world, with the mission of improving the health of populations–especially the disadvantaged, underserved, and vulnerable–locally and globally.

Contact:

Michelle Samuels, 617-358-3370, [email protected]

Michael Stein: [email protected]

Ekaterina Pivovarova: [email protected]

Media Contact
Michelle Samuels
[email protected]
http://dx.doi.org/10.1111/add.14699

Tags: AddictionMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Unlocking the Mysteries of Alzheimer’s Disease

July 2, 2026

Linking Single-Cell Transcriptomes to Mouse Visual Circuits

July 2, 2026

Cross-Stage, Cross-Species Malaria CD8+ T Cell Antigens Identified

July 2, 2026

Food Web Complexity Drives Biodiversity Impact

July 2, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Steatosis Drives Liver Metastasis Diversity in CRC

Unlocking the Mysteries of Alzheimer’s Disease

Pensoft Introduces New Peer-Reviewed Journal of Regeneration to Advance Restorative Biology Across Species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.